Loading...
A review of current progress in triple-negative breast cancer therapy
Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets. Researchers are aiming to advance TNBC treatment worldwide. In the past 2–3 years, more positive results have em...
Na minha lista:
| Udgivet i: | Open Med (Wars) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
De Gruyter
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718625/ https://ncbi.nlm.nih.gov/pubmed/33336070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2020-0138 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|